Midland Region community hepatitis C service

The regional hepatitis C community based service is now available. The purpose of the service is to provide:

Fibroscan  and patient education in the community and closer to the patients home

  • Clinically lead services delivered within the regionally agreed clinical pathway of care e.g. Map of Medicine and Bay Navigator
  • Geographical coverage across the five Midland DHBs
  • Clinical oversight within the service
  • Reduction in health disparity

 Background

Previously the Ministry of Health (MoH) contracted the Hepatitis Foundation of New Zealand (HFNZ) to run a pilot to improve hepatitis C services. The pilot was based in the Bay of Plenty DHB region. Following the pilot a regional hepatitis C project working group was established to develop a pathway of care and, wherever possible, implement lessons learnt from the pilot. The working group had representation from general practice, PHO’s, clinical nurse specialists, specialists, HFNZ, Maori Health and a consumer.

Who’s providing the service?

Waikato District Health Board (WDHB) has been awarded the contract following an Expression of Interest (EOI) and Request for Proposal (RFP) process. They are expanding their successful hepatitis C clinic which utilises a fixed Fibroscan based at Waikato hospital and by purchasing a mobile Fibroscan enabling more community based access, i.e. scans at community venues, prisons and needle exchange.

WDHB are working in partnership with HFNZ who also has a mobile Fibroscan to ensure geographical coverage, and reduce disparity wherever possible. Patients will be booked into clinics across the Midland DHB region. 

What service is being provided?

The service provides a Fibroscan which measures liver stiffness and is recommended for all patients with chronic hepatitis C, plus if the patient is eligible, a requirement for treatment.

At the Fibroscan appointment the scan result will be discussed with the patient also lifestyle education, monitoring and treatment options will be discussed.